Improved Pharma Showcases Innovative Research at AAPS 2025 PHARMSCI 360

Introduction to Improved Pharma at AAPS 2025

Improved Pharma is set to make a significant impact at AAPS 2025, the annual event for pharmaceutical scientists, where pharmaceutical innovations and research will be highlighted. This year, the company has expanded its presence with a larger booth (#3561) alongside Varda Space Industries (#3563), strategically located near key areas of interest including the main stage and Poster Forum 7. The team at Improved Pharma, led by notable figures including Stephen Byrn and Pam Smith, invites attendees to engage in discussions around their latest research, particularly focusing on solid-state chemistry and formulation design.

Research Focus on Amorphous Solid Dispersions

One of the highlights of Improved Pharma’s participation this year is the selection of their research for a prestigious Special Poster Collection on Amorphous Solid Dispersions. On November 10, Dr. Pamela Smith, the COO of Improved Pharma, will present groundbreaking findings titled "The Use of Raman Mapping and Hot-Stage Microscopy to Detect Micro-Domains of Crystallinity in Amorphous Solid Dispersions of Nilotinib." This session is not only significant due to the advanced analytical techniques discussed but also because it showcases how nuanced discoveries in pharmaceutical formulations can lead to improved drug therapies. The session will take place from 10:30 AM to 11:25 AM at Poster Forum 4.

Each participant in this special collection will have approximately ten minutes to present their findings and engage in a Q&A, making it an invaluable opportunity for collaboration and knowledge exchange among experts.

Joint Poster Presentation with BASF

In addition to its own presentations, Improved Pharma has joined forces with BASF to present a joint poster titled "Critical Insights into High Drug Load Amorphous Formulations Challenges and Advanced Techniques." Presented by Dr. Nitin Kumar K. Swarnakar from BASF at poster M1330-08-54, this research delves into the complexities faced during the scale-up of drug formulations and how these can impact dissolution results. The discussion emphasizes the use of advanced tools like Raman mapping as a necessary approach for ensuring uniform quality in pharmaceutical production.

Improved Pharma’s Commitment to Pharmaceutical Advancements

Founded in 2006 by Stephen and Sarah Byrn, Improved Pharma has built a reputation as a leader in pharmaceutical research and innovation. The company's comprehensive services range from solid-state form studies and formulation design to expert consulting and analytical testing. They are particularly noted for their work in enhancing pharmaceutical processes and defending intellectual property rights. This year's AAPS 2025 presents a platform for Improved Pharma not only to showcase their substantial research but also to continue fostering relationships within the pharmaceutical community.

Conclusion

As AAPS 2025 approaches, attendance at Improved Pharma's booth (#3561) promises to provide insight into the future of pharmaceutical development, particularly in the areas of solid-state chemistry and formulation. With a focus on collaboration and innovation, Improved Pharma aims to lead discussions that will shape the next generation of drug therapies and pharmaceutical practices. Don't miss the chance to learn from industry leaders and deepen your understanding of critical advancements in the field.

Visit Improved Pharma

Be sure to visit Improved Pharma at AAPS 2025, where they will be available to discuss research and answer questions about pharmaceutical development and formulation design. The event stands as a reminder of the continual evolution and improvement within the pharmaceutical sciences, reinforcing the importance of innovation in delivering effective healthcare solutions.